BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8564126)

  • 1. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases.
    Drent M; van Nierop MA; Gerritsen FA; Wouters EF; Mulder PG
    Am J Respir Crit Care Med; 1996 Feb; 153(2):736-41. PubMed ID: 8564126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in BAL fluid variables in interstitial lung diseases evaluated by discriminant analysis.
    Drent M; Mulder PG; Wagenaar SS; Hoogsteden HC; van Velzen-Blad H; van den Bosch JM
    Eur Respir J; 1993 Jun; 6(6):803-10. PubMed ID: 8339798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer program supporting the diagnostic accuracy of cellular BALF analysis: a new release.
    Drent M; Jacobs JA; Cobben NA; Costabel U; Wouters EF; Mulder PG
    Respir Med; 2001 Oct; 95(10):781-6. PubMed ID: 11601741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of age on manifestation, VC and TLCO values, and bronchoalveolar lavage cell counts of sarcoidosis and extrinsic allergic alveolitis.
    Sterclova M; Paluch P; Skibova J; Vasakova M
    Clin Respir J; 2015 Jan; 9(1):39-44. PubMed ID: 24406019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphometric and DNA image analysis of bronchoalveolar lavage fluid macrophages nuclei in interstitial lung diseases with lymphocytic alveolitis.
    Smojver-Jezek S; Peros-Golubicić T; Tekavec-Trkanjec J; Alilović M; Vrabec-Branica B; Juros Z; Mazuranić I
    Coll Antropol; 2010 Mar; 34(1):123-9. PubMed ID: 20432740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience.
    Domagała-Kulawik J
    Diagn Cytopathol; 2008 Dec; 36(12):909-15. PubMed ID: 18855907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases.
    Specks U; Martin WJ; Rohrbach MS
    Am Rev Respir Dis; 1990 Jan; 141(1):117-23. PubMed ID: 2153351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis.
    Sokhatska O; Padrão E; Sousa-Pinto B; Beltrão M; Mota PC; Melo N; Delgado L; Morais A
    BMC Pulm Med; 2019 Feb; 19(1):39. PubMed ID: 30760244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoalveolar lavage in interstitial lung diseases: does the recovery rate affect the results?
    Schildge J; Nagel C; Grun C
    Respiration; 2007; 74(5):553-7. PubMed ID: 17496412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoalveolar lavage in sarcoidosis.
    Drent M; Mansour K; Linssen C
    Semin Respir Crit Care Med; 2007 Oct; 28(5):486-95. PubMed ID: 17975776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory proteins in bronchoalveolar lavage fluid. A comparative analysis of pigeon breeders' disease, sarcoidosis and idiopathic pulmonary fibrosis.
    Reynolds SP; Jones KP; Edwards JH; Davies BH
    Sarcoidosis; 1989 Sep; 6(2):125-34. PubMed ID: 2602684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter?
    Domagała-Kulawik J; Skirecki T; Maskey-Warzechowska M; Grubek-Jaworska H; Chazan R
    Inflammation; 2012 Jun; 35(3):803-9. PubMed ID: 21882075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases.
    Efared B; Ebang-Atsame G; Rabiou S; Diarra AS; Tahiri L; Hammas N; Smahi M; Amara B; Benjelloun MC; Serraj M; Chbani L; El Fatemi H
    J Negat Results Biomed; 2017 Mar; 16(1):4. PubMed ID: 28245857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon gamma (IFN-gamma) level in broncholaveolar lavage (BAL) fluid is positively correlated with CD4/CD8 ratio in selected interstitial lung diseases].
    Kopiński P; Przybylski G; Jarzemska A; Sładek K; Soja J; Iwaniec T; Balicka-Slusarczyk B; Pinis G; Dyczek A; Szabłowska K; Golińska J; Jankowski M; Szczeklik J
    Pol Merkur Lekarski; 2007 Jul; 23(133):15-21. PubMed ID: 18051824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases.
    Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Striz I
    Respir Med; 2009 May; 103(5):773-9. PubMed ID: 19117745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases.
    Welker L; Jörres RA; Costabel U; Magnussen H
    Eur Respir J; 2004 Dec; 24(6):1000-6. PubMed ID: 15572545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of induced sputum in interstitial lung disease].
    Sobiecka M; Kuś J; Jóźwik A; Demkow U; Filewska M; Szołkowska M
    Pneumonol Alergol Pol; 2011; 79(1):6-15. PubMed ID: 21190147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
    Vuorinen K; Myllärniemi M; Lammi L; Piirilä P; Rytilä P; Salmenkivi K; Kinnula VL
    APMIS; 2007 Aug; 115(8):969-75. PubMed ID: 17696954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.